Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration.

Ruiz-Medrano J, Zamorano M, de Alboran CM, Ruiz-Moreno JM

Open source

DOI: 10.1186/s40942-026-00916-0
Published: 2026 Aug 4
Container: International journal of retina and vitreous
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40942-026-00916-0,
  title = {Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration.},
  author = {Ruiz-Medrano J and Zamorano M and de Alboran CM and Ruiz-Moreno JM},
  year = {2026},
  journal = {International journal of retina and vitreous},
  doi = {10.1186/s40942-026-00916-0},
  url = {https://doi.org/10.1186/s40942-026-00916-0}
}

RIS

TY  - JOUR
TI  - Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration.
AU  - Ruiz-Medrano J
AU  - Zamorano M
AU  - de Alboran CM
AU  - Ruiz-Moreno JM
PY  - 2026
JO  - International journal of retina and vitreous
DO  - 10.1186/s40942-026-00916-0
UR  - https://doi.org/10.1186/s40942-026-00916-0
ER  -

APA

J, R., M, Z., CM, D. A., & JM, R. (2026). Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration.. International journal of retina and vitreous. https://doi.org/10.1186/s40942-026-00916-0

Source records

pubmed · retrieved 2026-09-26T14:31:34.319Z
europe-pmc · retrieved 2026-09-26T14:31:34.320Z
doaj · retrieved 2026-09-26T14:31:34.294Z